Back to the main directory
Press Release
- Nuvectis Pharma, Inc. Reports Third Quarter 2022 Financial Results and Business Highlights by GlobeNewsWire
- Tempest Reports Third Quarter 2022 Financial Results and Provides Business Update by GlobeNewsWire
- PMV Pharmaceuticals Reports Third Quarter 2022 Financial Results and Corporate Highlights by GlobeNewsWire
- Akari Therapeutics Announces the Appointment of John F. Neylan, III, MD as Executive Vice President, Chief Medical Officer by GlobeNewsWire
- Core Molding Technologies Reports Fiscal 2022 Third Quarter Results by GlobeNewsWire
- Oxford Lane Capital Corp. Provides October Net Asset Value Update by GlobeNewsWire
- ProPhase Labs Announces Collaboration with Dana-Farber Cancer Institute by GlobeNewsWire
- Mobilicom Appoints Former COO of GuardKnox and Ex Fighter Jet Pilot as General Manager to Lead its Global Operations Hub in Israel by GlobeNewsWire
- AgileThought Expands in South America with a new Office in Buenos Aires, Argentina by GlobeNewsWire
- Achieve Announces Early Completion of Target Enrollment in Cytisinicline e-Cigarette Cessation Trial by GlobeNewsWire
- EQS-News: If You’re Trying To Hedge Inflation, Phosphate Is A Commodity To Keep Your Eye On by EQS Group AG
- Scholar Rock to Participate in Upcoming Investor Conferences by BusinessWire
- AtriCure to Present at 34th Annual Piper Sandler Healthcare Conference by BusinessWire
- Alliance Trust PLC - Net Asset Value by GlobeNewsWire
- Fifth Third Bank Expands Cash/Back Credit Card Suite by BusinessWire
- Zealand Pharma to Participate in Upcoming Investor Conferences by GlobeNewsWire
- RAPPEL : Papiers Tissu KP publiera ses résultats financiers et ceux de Produits Kruger S.E.C. pour le troisième trimestre de l’exercice 2022 by GlobeNewsWire
- RAPPEL : Stella-Jones tiendra une téléconférence pour discuter de ses résultats financiers du troisième trimestre 2022 by GlobeNewsWire
- BBSI Announces Launch of BBSI U Learning Management System by GlobeNewsWire
- Alaunos Therapeutics to Report Third Quarter 2022 Financial Results on November 14, 2022 by GlobeNewsWire
- Zai Lab to Present New Oncology Research at 2022 Society for Immunotherapy of Cancer Annual Meeting by GlobeNewsWire
- SAB Biotherapeutics Presents ‘Novel Biologic Therapeutics for Infectious Diseases’ at U.S. Pharma Partnering Summit 2022 by GlobeNewsWire
- Rodedawg International Industries, Inc. (OTC: RWGI) Provides Shareholder Year End Update by GlobeNewsWire
- Blue Water Vaccines Announces Appointment of Vuk Jeremić, Previous Chair of the Council of Europe’s Committee of Ministers and Previous President of the United Nations General Assembly, to Its Board of Directors by GlobeNewsWire
- Form 8.3 - The Vanguard Group, Inc.: AVEVA Group plc by EQS Group AG